Uniprot AC	Entrez ID	Gene Name	Disease	Cell Type	PTM Type	State	Position	PMID
P11166	6513	SLC2A1 GLUT1	Glut1 deficiency syndrome		Glycosylation	N	N45	
P11166	6513	SLC2A1 GLUT1	Hepatocellular carcinoma		Glycosylation	N	N45	
P11166	6513	SLC2A1 GLUT1	Stomach adenocarcinoma		Glycosylation	N	N45	
P11166	6513	SLC2A1 GLUT1	Glut1 deficiency syndrome		N-linked glycosylation	N	N45	
P11166	6513	SLC2A1 GLUT1	Hepatocellular carcinoma		N-linked glycosylation	N	N45	
P11166	6513	SLC2A1 GLUT1	Stomach adenocarcinoma		N-linked glycosylation	N	N45	
P11166	6513	SLC2A1 GLUT1	Colon adenocarcinoma		Phosphorylation	N	S226	
P11166	6513	SLC2A1 GLUT1	Epilepsy		Phosphorylation	N	S226	
P11166	6513	SLC2A1 GLUT1	Glut1 deficiency syndrome		Phosphorylation	N	S226	
P11166	6513	SLC2A1 GLUT1	Uterine corpus endometrial carcinoma		Phosphorylation	N	S226	
P11166	6513	SLC2A1 GLUT1	Colon adenocarcinoma		Phosphorylation	N	T234	
P11166	6513	SLC2A1 GLUT1	Epilepsy		Phosphorylation	N	T234	
P11166	6513	SLC2A1 GLUT1	Glioblastoma multiforme		Phosphorylation	N	T234	
P11166	6513	SLC2A1 GLUT1	Glut1 deficiency syndrome		Phosphorylation	N	T234	
P11166	6513	SLC2A1 GLUT1	Uterine corpus endometrial carcinoma		Phosphorylation	N	T234	
P11166	6513	SLC2A1 GLUT1	Colon adenocarcinoma		Phosphorylation	N	T238	
P11166	6513	SLC2A1 GLUT1	Epilepsy		Phosphorylation	N	T238	
P11166	6513	SLC2A1 GLUT1	Glioblastoma multiforme		Phosphorylation	N	T238	
P11166	6513	SLC2A1 GLUT1	Glut1 deficiency syndrome		Phosphorylation	N	T238	
P11166	6513	SLC2A1 GLUT1	Uterine corpus endometrial carcinoma		Phosphorylation	N	T238	
P11166	6513	SLC2A1 GLUT1	Epilepsy		Ubiquitination	N	K245	
P11166	6513	SLC2A1 GLUT1	Glut1 deficiency syndrome		Ubiquitination	N	K245	
P11166	6513	SLC2A1 GLUT1	Testicular germ cell tumor		Ubiquitination	N	K245	
P11166	6513	SLC2A1 GLUT1	Glut1 deficiency syndrome		Phosphorylation	N	T258	
P11166	6513	SLC2A1 GLUT1	Glut1 deficiency syndrome		O-linked glycosylation	N	S465	
P11166	6513	SLC2A1 GLUT1	Prostate adenocarcinoma		O-linked glycosylation	N	S465	
P11166	6513	SLC2A1 GLUT1	Glut1 deficiency syndrome		Phosphorylation	N	S465	
P11166	6513	SLC2A1 GLUT1	Prostate adenocarcinoma		Phosphorylation	N	S465	
P11166	6513	SLC2A1 GLUT1	Glut1 deficiency syndrome		Phosphorylation	C	S473	
P11166	6513	SLC2A1 GLUT1	Glut1 deficiency syndrome		Phosphorylation	N	S473	
P11166	6513	SLC2A1 GLUT1	Prostate adenocarcinoma		Phosphorylation	N	S473	
P11166	6513	SLC2A1 GLUT1	Skin cutaneous melanoma		Phosphorylation	N	S473	
P11166	6513	SLC2A1 GLUT1	Glut1 deficiency syndrome		SUMOylation	N	K477	
P11166	6513	SLC2A1 GLUT1	Skin cutaneous melanoma		SUMOylation	N	K477	
P11166	6513	SLC2A1 GLUT1	Glut1 deficiency syndrome		Ubiquitination	N	K477	
P11166	6513	SLC2A1 GLUT1	Skin cutaneous melanoma		Ubiquitination	N	K477	
P11166	6513	SLC2A1 GLUT1	Glut1 deficiency syndrome		Phosphorylation	N	T478	
P11166	6513	SLC2A1 GLUT1	Skin cutaneous melanoma		Phosphorylation	N	T478	
P11166	6513	SLC2A1 GLUT1	Glut1 deficiency syndrome		Phosphorylation	N	S490	
P11166	6513	SLC2A1 GLUT1	Glioma	brain tissues	N-linked glycosylation	U		31494931
P11166	6513	SLC2A1 GLUT1	Bladder cancer	tumor tissue	Ubiquitination	D		34906161
P11166	6513	SLC2A1 GLUT1	Glioblastoma	tumor tissue	S-palmitoylation	P	C207	34620861
P11166	6513	SLC2A1 GLUT1	Bladder cancer	BLCA tissue	O-linked glycosylation	U		38542435
